By Scientia Professor Matthew Colm Kiernan

Books

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.

Book Chapters

Park SB; Kiernan MC, 2023, 'Chemotherapy-Induced Cranial Nerve Damage', in Cranial Nerves in Neurology A Comprehensive and Systematic Evaluation of Cranial Nerves Pathology and Specific Conditions, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23

Vucic S; Kiernan MC, 2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138

Tu S; Kiernan MC, 2023, 'Chapter 14 Amyotrophic lateral sclerosis', in Imaging Neuroinflammation, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2

Vucic S; Kiernan MC, 2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1

Dharmadasa T; Huynh W; Kiernan MC, 2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia the Neuroscience of Dementia Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5

Huynh W; Lee M; Kiernan MC, 2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press, pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918

Huynh W; Dharmadasa T; Agarwal S; Caga J; Kiernan MC, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Routledge, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9

Hardiman O; Kiernan MC; Van den Berg LH, 2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders A Clinical Guide Second Edition, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8

huynh W; lee M; kiernan MC, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235

Kiernan MC, 2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9

Vucic S; Kiernan MC, 2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138

, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376

Farrar M; Kiernan MC, 2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2

Park SB; Kiernan MC, 2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b

Park SB; Kiernan MC, 2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3

Vucic O; Burke D; Kiernan MC, 2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104

Kiernan MC, 2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181

Lin CS; Kiernan MC; Burke D; Bostock H, 2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403

Burke D; Kiernan MC, 2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy 2 Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9

KIERNAN MC; BURKE D; BOSTOCK H, 2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9

Kiernan MC; Burke D; Bostock H, 2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129

Kiernan MC; Burke D, 2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366

Kiernan MC, 2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences Volumes 1 4, pp. V2-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3

Kiernan MC, 2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642

Burke DJ; Mogyoros I; Kiernan MC; Bostock H, 1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154

Burke DJ; Kiernan MC; Mogyoros I; Bostock H, 1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53

Journal articles

Kim SH; Noh MY; Kiernan MC, 2026, 'Neurodegeneration as an evolutionary trade-off: a biological constraint–aware therapeutic perspective', Molecular Neurodegeneration, 21, http://dx.doi.org/10.1186/s13024-026-00958-w

Vucic S; Cheah BC; Krishnan AV; Burke D; Kiernan MC, 2026, 'Corrigendum to “The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition” [Brain Res. 1273 (2009) 39–47]', Brain Research, 1889, http://dx.doi.org/10.1016/j.brainres.2026.150475

Pavey N; Tu S; Foster S; Geevasinga N; Calma A; Tsuji Y; Kiernan MC; Vucic S; Menon P, 2026, 'Cortical changes in amyotrophic lateral sclerosis: comparing biomarkers of glymphatic flow and cortical excitability', Clinical Neurophysiology, 190, http://dx.doi.org/10.1016/j.clinph.2026.2111949

Zussa ZN; Smith AN; van Vugt JJFA; O’Shaughnessy DS; Grima N; Chan Moi Fat S; Blair IP; Rowe DB; Pamphlett R; Nicholson GA; Kiernan MC; van Rheenen W; Veldink J; Williams KL; Henden L, 2026, 'Characterising the motif composition and allele length distribution of ZFHX3 GGC repeat expansions in amyotrophic lateral sclerosis', Journal of Human Genetics, pp. 1 - 8, http://dx.doi.org/10.1038/s10038-026-01513-7

Shrestha N; Munn Z; Calma A; Pavey N; Tsuji Y; Menon P; Padovani A; Risi B; Ferullo L; Filosto M; Jewett G; Shibuya K; Otani R; Shimizu T; Kuwabara S; Noto YI; Kitaoji T; Johnsen B; Shen D; Cui L; van den Berg LH; van Eijk RPA; van Damme P; Kiernan MC; Giles L; Vucic S, 2026, 'Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis', Journal of Neurology, 273, http://dx.doi.org/10.1007/s00415-026-14046-y

Hannaford AM; Supnet IE; Pavey N; Menon P; van den Bos MAJ; Kiernan MC; van Alfen N; Simon NG; Vucic S, 2026, 'Muscle Ultrasound Is a Sensitive Outcome Measure in ALS', Muscle and Nerve, 74, pp. 590 - 599, http://dx.doi.org/10.1002/mus.70317

Isik FI; Pickford R; Timmins HC; Piguet O; Halliday GM; Kiernan MC; Kim WS, 2026, 'Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum', FEBS Open Bio, 16, pp. 1550 - 1562, http://dx.doi.org/10.1002/2211-5463.70232

D'Silva A; Herbert K; Balaji L; He JM; Kandula T; Sampaio HA; Teoh HL; Tantsis E; Sohn J; Briggs N; Ning N; Kiernan MC; Kariyawasam DS; Farrar MA, 2026, 'The Dynamics of Neurofilament Light Chain in Spinal Muscular Atrophy', Annals of Neurology, 100, pp. 109 - 122, http://dx.doi.org/10.1002/ana.78207

Swart G; Garg N; Yiannikas C; Vucic OS; Pollard J; Carroll A; Silsby M; Kiernan M; Spies J; Park S, 2026, 'Measuring Disease Activity During Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (P7-9.003)', Neurology, 106, http://dx.doi.org/10.1212/wnl.0000000000217482

Swart G; Garg N; Skolka MP; Yiannikas C; Vucic S; Pollard JD; Carroll AS; Silsby M; Spies J; Kiernan MC; Klein CJ; Park SB, 2026, 'Application of a Clinical-Electrophysiological Model for Identifying Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Australian Cohort', Journal of the Peripheral Nervous System, 31, http://dx.doi.org/10.1111/jns.70125

Henders AK; Ziser L; Garton FC; Adams L; Ernst K; Furlong S; Heads JA; Heggie S; Krasniqi R; Bhadravathi Lokeshappa M; Mazumder S; McNamara E; MacShane A; Mekhael L; Nunn L; Orden B; Ryder J; Thorpe K; Toubia M; Wallace LM; Wickremeratne D; Windebank E; Benyamin B; Ngo S; Nicholson G; Pamphlett R; Steyn FJ; Visscher PM; Willams KL; Henderson R; Kiernan MC; Laing N; Mathers S; McCombe PA; Needham M; Rowe D; Schultz D; Talman P; Vucic S; Blair IP; McRae AF; Wray NR, 2026, 'Strategic Amyotrophic Lateral Sclerosis Australia–Systems Genomics Consortium (SALSA-SGC): cohort profile', BMJ Open, 16, http://dx.doi.org/10.1136/bmjopen-2025-110906

Calma AD; Pavey N; Silva CS; Tsuji Y; Ghapar AA; Morris K; Kiernan MC; Farrar MA; Menon P; Vucic S, 2026, 'Utility of Far-Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy', Muscle and Nerve, 73, pp. 1089 - 1095, http://dx.doi.org/10.1002/mus.70231

Haidar M; Viden A; Daniel C; Cuic B; Wang T; Rosier M; Tomas D; Mills SA; Govier-Cole A; Djouma E; Perera ND; Luikinga S; Rytova V; Barton SK; Gonsalvez DG; Palmer LM; McLean C; Kiernan MC; Vucic S; Turner BJ, 2026, 'Corrigendum to “Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice”[Prog. Neurobiol. 252 (2025) 102809]', Progress in Neurobiology, 260, http://dx.doi.org/10.1016/j.pneurobio.2026.102910

Hop PJ; Kooyman M; Kenna BJ; Zwamborn RAJ; van Eijk KR; Wang Y; van Dijk CH; Bekema E; van Rheenen W; Beele P; van Vugt JJFA; de Carvalho M; van den Berg LH; Van Damme P; Smith BN; Khleifat AA; Iacoangeli A; Cooper-Knock J; Smith BN; Topp S; van der Kooi AJ; Fominykh V; Drory V; Lerner Y; Shovman Y; Rowe DB; Williams KL; McLaughlin RL; Hurt J; Huang Y; Chen CY; Tsai E; Runz H; Aronica E; Groen EJN; van Es MA; Pasterkamp RJ; Farhan SMK; Garton FC; McRae AF; McCombe PA; Henderson RD; Fan D; Šlachtová L; Høyer H; Nishimura AL; Cauchi RJ; Brylev L; Rogelj B; Koritnik B; Zidar J; Salas T; Mora Pardina JS; Gotkine M; Povedano M; Corcia P; Vourc’h P; Couratier P; Weber M; Kiernan MC; Pamphlett R; Blair IP; de Carvalho M; Başak NA; Ingre C; Andersen PM; Zinman L; Rogaeva E; MacKenzie IR; Dupre N; Rouleau GA; Traynor BJ; Ticozzi N; Chiò A; Silani V; Hardiman O; Phatnani H; Harms MB; Dalgard CL; Glass JD; Landers JE; Van Damme P; Morrison KE; Shaw PJ; Shaw CE; Al-Chalabi A; van den Berg LH; Kenna KP; Veldink JH, 2026, 'Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis', Nature Genetics, 58, pp. 717 - 725, http://dx.doi.org/10.1038/s41588-026-02535-9

Rudnicki SA; Giacomelli E; Herder K; Ingre C; Kupfer S; Malik FI; Meng L; Paganoni S; Schellenberg K; Scirocco E; Simkins T; Wei J; Shefner JM; Henderson RD; Kiernan MC; Schultz D; Needham M; Vucic S; Johnston W; Zinman L; Genge A; Matte G; O’Connell CM; Korngut L; Dionne A; Turnbull J; Schellenberg K; Shoesmith C; Zwicker J; Salvesen L; Couratier P; Corcia P; Bernard E; Salachas F; Danel V; Attarian S; Soriani MH; Ludolph A; Petri S; Rödiger A; Großkreutz J; Weydt P; Meyer T; Hardiman O; Chio A; Silani V; Cerri F; Calvo A; Lunetta C; van den Berg LH; Kusma-Kozakiewicz M; de Carvalho M; Mora JS; Vazquez-Costa JF; Povedano M; Ingre C; Nilsson C; Weber M; Al-Chalabi A; Young C; Andrews JA; Markgakis NJ; Miller TM; Simmons Z; Heiman-Patterson T; Cudkowicz ME; Bradshaw D; Paganoni S; Statland J; Grogan J; Rothstein J; Oskarsson B; Vu T; Olney N; Lewis R; Katz J; Quan D; Mccluskey L; Goyal N; Pavlakis P; Swenson A; Bayat E; Goutman S; Fee D; Creigh P; Peltier A; Heitzman D; Patee G; Bodkin C; Owegi M; Arcilla-London X; Chahin N; Ladha S; So Y; Rezania K; Tandan R; Kuenzler R; Gwathmey K; Pulley M, 2026, 'The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS', Muscle and Nerve, 73, pp. 608 - 614, http://dx.doi.org/10.1002/mus.70150

Wu SSL; McCann EP; Chan Moi Fat S; Grima N; Henden L; Fearnley LG; Chiu P; Williams KL; Rowe DB; Nicholson GA; Kiernan MC; Blair IP; Yang S; Fifita JA, 2026, 'Genetic characterisation of ATXN2 in Australian amyotrophic lateral sclerosis', Brain Disorders, 21, http://dx.doi.org/10.1016/j.dscb.2025.100301

Tu S; Mahoney CJ; Huynh W; Vucic S; Kiernan MC, 2026, 'Cortical excitability stratifies neurochemical profiles in amyotrophic lateral sclerosis', Brain Communications, 8, http://dx.doi.org/10.1093/braincomms/fcag292

Calma AD; Pavey N; Tsuji Y; Ghapar AA; Bos MAJVD; Orden B; Lee G; Mekhael L; Ryder J; Silva CS; McDonald D; Kakar F; Yiannikas C; Kiernan MC; Brown DA; Menon P; Vucic S, 2026, 'Integration of Serum Neurofilament Light Chain and Cortical Dysfunction Improves Diagnostic Accuracy in ALS', Annals of Clinical and Translational Neurology, http://dx.doi.org/10.1002/acn3.70454

Bye CR; Qian E; Lim K; Daniszewski M; Garton FC; Trần-Lê BC; Liang HH; Lin T; Lock JG; Crombie DE; Morgan S; Hu Y; Barton SK; Palmer LM; Djouma E; Kodikara S; Lê Cao KA; Dharmadasa T; Henders AK; Ziser LA; Kiernan MC; Talbot K; Needham M; Fletcher S; Talman P; Mathers S; Wray NR; Hewitt AW; Pebay A; Turner BJ, 2026, 'Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy', Nature Neuroscience, 29, pp. 40 - 52, http://dx.doi.org/10.1038/s41593-025-02118-7

Kiernan MC; Genge A; Grosskreutz J; Kuwabara S; Lillo P; Rosenfeld J; Cummings C, 2026, 'The World Federation of Neurology Specialty Group in ALS/MND: toward strategic partnership and new frontiers', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 27, pp. 501 - 503, http://dx.doi.org/10.1080/21678421.2026.2663915

Back to profile page